In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models

Executive Summary

Medtech manufacturers saw 2014 as the year of the medtech mega-merger and a rebound in IPOs. But the market is changing, and companies are increasingly cast as service providers who must deliver value.


Related Content

Medtech M&A: Mid-Tiers Poised To Strike In 2015
Biopharma In 2014: Early Access Gains Offset Taxation, Pricing Woes
Diagnostics In 2014: More Of The Same
Philips Increases Bet On Imaged-Guided Therapy With Volcano Buy
Abbott, NEA Show Medtech Deals Still Have Some Pop
Digital Health Pushing Telemedicine To Center Stage
J&J’s Approach To Sourcing Innovation: Closing The Networking Gap
Medtronic And Covidien Continue Shopping In Advance Of Pairing
InfraReDx’s Long Road To Commercialization Continues With Latest Financing
Avinger: Finally, Seeing Through Total Occlusions, But Will Clinical Value Generate Economic Return?


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts